Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter A Cohen

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|June 27, 2006
The red hatPieter A Cohen
JAMA Internal Medicine|February 5, 2019
Probiotic Safety-Reasonable Certainty of No Harm-ReplyPieter A Cohen
Archives of Internal Medicine|April 25, 2012
Coronary artery calcium scanning and conflicts of interestPieter A Cohen
Journal of General Internal Medicine|December 20, 2008
Imported fenproporex-based diet pills from Brazil: a report of two casesPieter A Cohen
Mayo Clinic Proceedings|October 6, 2015
Vinpocetine: An Unapproved Drug Sold as a Dietary SupplementPieter A Cohen
Lancet (London, England)|July 12, 2011
Phentermine plus topiramate in the treatment of obesityPieter A Cohen
The New England Journal of Medicine|January 27, 2012
Assessing supplement safety--the FDA's controversial proposalPieter A Cohen
Antioxidants & Redox Signaling|November 2, 2011
A false sense of security? The U.S. Food and Drug Administration's framework for evaluating new supplement ingredientsPieter A Cohen
JAMA Network Open|January 16, 2019
The FDA and Adulterated Supplements-Dereliction of DutyPieter A Cohen
JAMA Internal Medicine|April 10, 2013
DMAA as a dietary ingredient-replyPieter A Cohen
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Academic Medicine : Journal of the Association of American Medical Colleges|June 27, 2006
The red hatPieter A Cohen
JAMA Internal Medicine|February 5, 2019
Probiotic Safety-Reasonable Certainty of No Harm-ReplyPieter A Cohen
Archives of Internal Medicine|April 25, 2012
Coronary artery calcium scanning and conflicts of interestPieter A Cohen
Journal of General Internal Medicine|December 20, 2008
Imported fenproporex-based diet pills from Brazil: a report of two casesPieter A Cohen
Mayo Clinic Proceedings|October 6, 2015
Vinpocetine: An Unapproved Drug Sold as a Dietary SupplementPieter A Cohen
Lancet (London, England)|July 12, 2011
Phentermine plus topiramate in the treatment of obesityPieter A Cohen
The New England Journal of Medicine|January 27, 2012
Assessing supplement safety--the FDA's controversial proposalPieter A Cohen
Antioxidants & Redox Signaling|November 2, 2011
A false sense of security? The U.S. Food and Drug Administration's framework for evaluating new supplement ingredientsPieter A Cohen
JAMA Network Open|January 16, 2019
The FDA and Adulterated Supplements-Dereliction of DutyPieter A Cohen
JAMA Internal Medicine|April 10, 2013
DMAA as a dietary ingredient-replyPieter A Cohen
Pageof 7